Biological E’s novel oral type 2 polio vax gets WHO phase II PQ
HYDERABAD: The World Health Organization (WHO) has granted Phase II pre-qualification (PQ) to Biological E (BE)’s novel oral polio vaccine type 2 (nOPV2), which is used for controlling cVDPV2 outbreaks, the Hyderabad-based biopharma company said on Thursday.The Phase II PQ covers both the drug substance and drug product manufactured at BE, which completes the full…